Minimally Invasive Intracerebral Hematoma Evacuation Using a Novel Cost-Effective Tubular Retractor: Single-Center Experience.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
06 2021
Historique:
received: 25 12 2020
revised: 15 03 2021
accepted: 16 03 2021
pubmed: 28 3 2021
medline: 31 7 2021
entrez: 27 3 2021
Statut: ppublish

Résumé

Spontaneous intracerebral hematoma (ICH) is a common disease with a dismal overall prognosis. Recent development of minimally invasive ICH evacuation techniques has shown promising results. Commercially available tubular retractors are commonly used for minimally invasive ICH evacuation yet are globally unavailable. A novel U.S. $7 cost-effective, off-the-shelf, atraumatic tubular retractor for minimally invasive intracranial surgery is described. Patients with acute spontaneous ICH underwent microsurgical tubular retractor-assisted minimally invasive ICH evacuation using the novel retractor. Patient outcome was retrospectively analyzed and compared with open surgery and with commercial tubular retractors. Ten adult patients with spontaneous supratentorial ICH and median preoperative Glasgow Coma Scale score of 10 were included. ICH involved the frontal lobe, parietal lobe, occipitotemporal region, and solely basal ganglia in 3, 3, 2, and 2 patients, respectively. Mean preoperative ICH volume was 80 mL. Mean residual hematoma volume was 8.7 mL and mean volumetric hematoma reduction was 91% (median, 94%). Seven patients (70%) underwent >90% volumetric hematoma reduction. The total median length of hospitalization was 26 days. On discharge, the median Glasgow Coma Scale score was 12.5 (mean, 11.7). Thirty to 90 days' follow-up data were available for 9 patients (90%). The mean follow-up modified Rankin Scale score was 3.7 and 5 patients (56%) had a modified Rankin Scale score of 3. The novel cost-effective tubular retractor and microsurgical technique offer a safe and effective method for minimally invasive ICH evacuation. Cost-effective tubular retractors may continue to present a valid alternative to commercial tubular retractors.

Sections du résumé

BACKGROUND
Spontaneous intracerebral hematoma (ICH) is a common disease with a dismal overall prognosis. Recent development of minimally invasive ICH evacuation techniques has shown promising results. Commercially available tubular retractors are commonly used for minimally invasive ICH evacuation yet are globally unavailable.
METHODS
A novel U.S. $7 cost-effective, off-the-shelf, atraumatic tubular retractor for minimally invasive intracranial surgery is described. Patients with acute spontaneous ICH underwent microsurgical tubular retractor-assisted minimally invasive ICH evacuation using the novel retractor. Patient outcome was retrospectively analyzed and compared with open surgery and with commercial tubular retractors.
RESULTS
Ten adult patients with spontaneous supratentorial ICH and median preoperative Glasgow Coma Scale score of 10 were included. ICH involved the frontal lobe, parietal lobe, occipitotemporal region, and solely basal ganglia in 3, 3, 2, and 2 patients, respectively. Mean preoperative ICH volume was 80 mL. Mean residual hematoma volume was 8.7 mL and mean volumetric hematoma reduction was 91% (median, 94%). Seven patients (70%) underwent >90% volumetric hematoma reduction. The total median length of hospitalization was 26 days. On discharge, the median Glasgow Coma Scale score was 12.5 (mean, 11.7). Thirty to 90 days' follow-up data were available for 9 patients (90%). The mean follow-up modified Rankin Scale score was 3.7 and 5 patients (56%) had a modified Rankin Scale score of 3.
CONCLUSIONS
The novel cost-effective tubular retractor and microsurgical technique offer a safe and effective method for minimally invasive ICH evacuation. Cost-effective tubular retractors may continue to present a valid alternative to commercial tubular retractors.

Identifiants

pubmed: 33771750
pii: S1878-8750(21)00453-8
doi: 10.1016/j.wneu.2021.03.083
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-53

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Alon Orlev (A)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel. Electronic address: dr.aorlev@gmail.com.

Gil Kimchi (G)

Department of Neurosurgery, Sheba Medical Center, Ramat-Gan, Israel.

Liat Oxman (L)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Idan Levitan (I)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

David Felzensztein (D)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Netanel Ben Shalom (N)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Shani Berkowitz (S)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Ido Ben Zvi (I)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Yosef Laviv (Y)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Giorgio Rubin (G)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Uzi Ben David (U)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Sagi Harnof (S)

Department of Neurosurgery, Rabin Medical Center, Petach Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH